SCHEMBL1126545

SCHEMBL1126545

COC(=O)c1sccc1-n1cccc1C(=O)C(=O)Nc1ccc(F)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 1.00
MEN1 O00255 5/20 0.63
KMT2A Q03164 5/20 0.63
MAPT P10636 5/20 0.60
LMNA P02545 2/20 0.60
TDP1 Q9NUW8 1/20 0.57
SMN1; SMN2 Q16637 5/20 0.56
CYP3A4 P08684 2/20 0.56
ALDH1A1 P00352 4/20 0.54
NPC1 O15118 5/20 0.52
RAB9A P51151 4/20 0.52
PKM P14618 3/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
RECQL P46063 1/20 0.49
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1126436 0.89 L3MBTL1 (0.81) L3MBTL1MEN1KMT2AMAPTLMNA
SCHEMBL1126417 0.89 L3MBTL1 (0.81) L3MBTL1MEN1KMT2AMAPTLMNA
SCHEMBL1126369 0.89 L3MBTL1 (0.80) L3MBTL1MEN1KMT2AMAPTLMNA
SCHEMBL1127288 0.80 L3MBTL1 (0.66) L3MBTL1MEN1KMT2AMAPTLMNA
SCHEMBL1126500 0.79 CYP3A4 (0.80) L3MBTL1MEN1KMT2AMAPTLMNA
SCHEMBL1126455 0.78 L3MBTL1 (0.64) L3MBTL1MEN1KMT2AMAPTLMNA
SCHEMBL1993125 0.78 MEN1 (1.00) L3MBTL1MEN1KMT2AMAPTLMNA
SCHEMBL1992068 0.68 MEN1 (1.00) L3MBTL1MEN1KMT2AMAPTLMNA
SCHEMBL8875381 0.67 MAPT (0.58) MEN1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL1126853 0.66 RAB9A (1.00) L3MBTL1MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2283006-B1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-02-25 EP claimed
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2011-06-23 US claimed
EP-2283006-A1 PYRROLE ANTIFUNGAL AGENTS F2G Limited (GB) 2011-02-16 EP claimed
WO-2009130481-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2009-10-29 WO claimed
US-9452168-B2 Pyrrole antifungal agents F2G LTD (GB) 2016-09-27 US disclosed
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-08-27 US disclosed
US-8993574-B2 Pyrrole antifungal agents F2G LTD (GB) 2015-03-31 US disclosed
EP-2283006-B1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-02-25 EP disclosed
EP-2626361-A1 Pyrrole antifungal agents F2G Limited (GB) 2013-08-14 EP disclosed
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2011-06-23 US disclosed
EP-2283006-A1 PYRROLE ANTIFUNGAL AGENTS F2G Limited (GB) 2011-02-16 EP disclosed
WO-2009130481-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 L3MBTL1 1045/4885MEN1 77/4885KMT2A 3996/4885
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 L3MBTL1 1045/4885MEN1 77/4885KMT2A 3996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.